Here are relevant reports on : immunoprotein-diagnostics-market
-
Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) & Region - Global Forecast to 2028
The global tissue diagnostics market, valued at US$5.2 billion in 2022, stood at US$5.6 billion in 2023 and is projected to advance at a resilient CAGR of 8.4% from 2023 to 2028, culminating in a forecasted valuation of US$8.4 billion by the end of the period. The new research study consists of an industry trend analysis of the market. Market growth is driven by the growing private diagnostic centers globally, and rising geriatric population with subsequent growth in chronic and infectious diseases.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics market is expected to grow from USD 33.83 billion in 2026 to USD 49.49 billion by 2031, at a compound annual growth rate (CAGR) of 7.9% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), Werfen (Spain), and Illumina, Inc. (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) & Region - Global Forecast to 2028
The global antimicrobial resistance (AMR) surveillance market, valued at US$5.4 billion in 2021, stood at US$5.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$7.7 billion by the end of the period.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029
According to MarketsandMarkets, the global Specialty enzymes market size is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% during the forecast period. Key players in this market include BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), Advanced Enzyme Technologies (India), Amano Enzyme Inc (Japan), F. Hoffmann-La Roche Ltd (Switzerland), New England Biolabs (US), BBI Solutions (UK), Creative Enzymes (US), Bioseutica (Netherland), and SEKISUI Diagnostics (US)
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Microplate Systems Market by Product (Microplate Reader (Multi-mode, Single-mode), Microplate Washer, Microplate Accessories), Application (Drug Discovery, Clinical Diagnostics) & End User (Hospital and Diagnostic Laboratories) - Global Forecast to 2026
The global microplate systems market in terms of revenue was estimated to be worth $927 million by 2021 and is poised to reach $1,170 million by 2026, growing at a CAGR of 4.8% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Immuno Oncology Assays Market Size, Share & Trends by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
The size of global immuno oncology assays market in terms of revenue was estimated to be worth USD 4.4 billion in 2021 and is poised to reach USD 7.9 billion by 2026, growing at a CAGR of 12.5% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market By Equipment (Oxygen delivery systems, CPAP, nebulizers, ventilators, IV diagnostics, home dialysis, insulin delivery devices, and other equipment)
In this report, we have analyzed how the home healthcare market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services.
- Published: February 2010
- Price: $ 4950
- TOC Available:
-
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), End-user, and Region - Global Forecast to 2029
The global cancer biomarkers market, valued at US$22.3 billion in 2023, stood at US$24.5 billion in 2024 and is projected to advance at a resilient CAGR of 11.3% from 2024 to 2029, culminating in a forecasted valuation of US$42.0 billion by the end of the period. The primary drivers of growth in this market are the rising incidence of cancer worldwide, increased research on cancer biomarkers, the growing use of biomarkers in drug discovery and development, and ongoing technical advancements.
- Published: April 2024
- Price: $ 7150
- TOC Available:
-
Electrophoresis Market by Product (Reagents (Protein & Nucleic Acid), (Gel Electrophoresis (1D & 2D), Capillary Electrophoresis (CZE, CGE), GDS, Software), Application (Research, Diagnostics), End User (Hospitals) & Region - Global Forecast to 2028
The global electrophoresis market, valued at US$2.9 billion in 2022, stood at US$3.1 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$4.1 billion by the end of the period. The growth in this market is attributed to the the growing industry-academia research collaboations, and increasing number of clinical, forensic and research labs screening will drive the growth of the market.
- Published: April 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
